Sunday, 26 May 2019

Japan News

  • Isogenica appoints CTC Lab Systems to tap Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Isogenica has appointed CTC Laboratory Systems (CTCLS) of Tokyo, Japan, to represent its business in Japan. CTCLS is a leading force in the pharmaceutical research market in Japa...Read more

  • ThermoGenesis sells product line to Asahi

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2012

    Singapore: ThermoGenesis, a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, has sold its CryoSeal Fibrin Sealant System wound car...Read more

  • Sanford-Burnham, Daiichi form new alliance

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year discovery and pre-clinical drug development partnership for cardiovascular...Read more

  • Takeda strives to enter Europe's type 2 diabetes market

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Singapore: Japan-based Takeda Global Research & Development Centre has received confirmation of the acceptance of submissions of marketing authorisation applications (MAAs) from the Eur...Read more

  • Bangkok to adopt Japanese technology to treat cancer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2014

    Singapore: Thailand hospital is planning to introduce Japanese cancer therapy technology using a heavy ion beam to treat cancer. The therapy involves targeting a beam of heavy ions at cance...Read more

  • Novartis under fire from Tasigna allegations

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

    Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigation under possible violation of the pharmaceutical affairs law. It has...Read more

  • Genmab in research deal with Kyowa Hakko Kirin

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific antibodies using Genmab's DuoBody technology. If successful, the parties ...Read more

  • Japanese-Thai program to fund three projects

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Singapore: Japan Science and Technology Agency (JST) and the National Science and Technology Development Agency (NSTDA) have developed a scheme for joint funding of Japanese-Thai cooperativ...Read more

  • Daiichi seeks approval for influenza antiviral in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the influenza antiviral product Inavir Dry Powder Inhaler (laninamivir o...Read more

  • Mitsubishi and Daiichi Sankyo to launch diabetes drug in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

    Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (teneligliptin hydrobromide hydrate tablets) in Japan on September 10, 2012...Read more

  • Pic Gallery - 7th in-Pharma Japan and 26th Interphex Japan

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...Read more

  • Pharma companies focus on supply chain in Japan

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

    Singapore: Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent expiries have compelled pharmaceutical industry leaders to rationalize thei...Read more

  • Takeda subsidiary suspended for 'no drug label'

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: Takeda Pharmaceutical received an Order for Corrective Action regarding the manufacturing and marketing of Alinamin-F5 Injection from the Osaka Prefectural Government, citing a v...Read more

  • Thermo Fisher enters into agreement Fujirebio

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory ins...Read more

  • Bayer colorectal cancer drug gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

    Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's Stivarga (regorafenib) tablets for the treatment of patients with me...Read more

  • Astellas, Ambit terminate cancer drug deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

    Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3)...Read more

  • Edison Pharma, DSP enter $4 bn metablosim drug deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more

  • Gilead files NDA for Hep C drug in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

    Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotid...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls